Reducing drug development costs
A new animation
Overview This short animation explains how we use Mendelian randomization and colocalization to help prioritise drug targets. One of our aims in both programme 4 of the MRC IEU and the Integrative Cancer Epidemiology Programme is to integrate such prioritizations with other data to help inform drug development.
Video About the animation The animation is based on recent work by Dr Jie (Chris) Zheng, Vice-Chancellors Fellow based in programme 4 of the MRC IEU, who recently published an innovative Mendelian randomization and colocalization study of plasma protein levels in Nature Genetics, that demonstrated how genetic data can be used to support drug target prioritisation by identifying the causal effects of proteins on diseases.